Last reviewed · How we verify
Creon（Pancreatin Enteric-coated Capsules）
Creon（Pancreatin Enteric-coated Capsules） is a Small molecule drug developed by Shanghai Changzheng Hospital. It is currently in Phase 1 development.
At a glance
| Generic name | Creon（Pancreatin Enteric-coated Capsules） |
|---|---|
| Sponsor | Shanghai Changzheng Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Management of Steatorrhea in Children and Young Adults With Alagille Syndrome After Liver Transplantation (PHASE2)
- A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With Chronic Pancreatitis (EARLY_PHASE1)
- Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis (NA)
- The Effect of PERT on Patients Undergoing Pancreaticoduodenectomy (PHASE4)
- Endotherapy for Painless Chronic Pancreatitis (NA)
- Equivalence Study to Compare Two Strengths of Creon in China (PHASE3)
- Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI) (PHASE3)
- Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis. (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Creon（Pancreatin Enteric-coated Capsules） CI brief — competitive landscape report
- Creon（Pancreatin Enteric-coated Capsules） updates RSS · CI watch RSS
- Shanghai Changzheng Hospital portfolio CI
Frequently asked questions about Creon（Pancreatin Enteric-coated Capsules）
What is Creon（Pancreatin Enteric-coated Capsules）?
Creon（Pancreatin Enteric-coated Capsules） is a Small molecule drug developed by Shanghai Changzheng Hospital.
Who makes Creon（Pancreatin Enteric-coated Capsules）?
Creon（Pancreatin Enteric-coated Capsules） is developed by Shanghai Changzheng Hospital (see full Shanghai Changzheng Hospital pipeline at /company/shanghai-changzheng-hospital).
What development phase is Creon（Pancreatin Enteric-coated Capsules） in?
Creon（Pancreatin Enteric-coated Capsules） is in Phase 1.